Overcoming Drug Delivery Challenges in Gastrointestinal Therapy with 3D Printing
Explore how 3D printing is solving drug delivery challenges in gastrointestinal therapy with customized dosage forms, enhancing outcomes.
Read More
Author: Andy Lundin
Enhancing Patient Safety: The Role of Pharmacovigilance in Risk Management of GI Drugs
Pharmacovigilance is key in managing risks associated with GI drugs. Discover how adverse event reporting and risk management plans enhance patient safety.
Read More
Addressing Disparities in Biologic Therapy Access: Solutions for Equity
Affordability and social disparities limit access to biologic therapy. Learn how biosimilars, patient assistance, and policy reforms can help
Read More
Future of Nanomedicine in GI Drug Delivery: From Targeted Therapies to Personalized Medicine
Nanomedicine is advancing GI drug delivery through targeted therapies and personalized treatments, offering more precise and effective care for gastrointestinal disorders.
Read More
Predictive Value of Serum Biomarkers in IBD: Forecasting Flare-Ups and Disease Progression
Serum biomarkers provide a proactive approach in predicting IBD flare-ups, aiding in early intervention and improved management of Crohn’s and ulcerative colitis.
Read More